Fosfomycin tromethamine in uncomplicated urinary tract infections: an epidemiological survey.
Tempera
G
G
Mirabile
M
M
Mangiafico
A
A
Caccamo
M
M
Bonfiglio
G
G
D000890:Anti-Infective Agents / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D004352:Drug Resistance, Microbial; D004926:Escherichia coli / Q000187:drug effects*; D005260:Female; D005578:Fosfomycin / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000494:pharmacology* / Q000627:therapeutic use; D006090:Gram-Negative Bacteria / Q000187:drug effects; D006094:Gram-Positive Bacteria / Q000187:drug effects; D006801:Humans; D007558:Italy / Q000453:epidemiology; D008826:Microbial Sensitivity Tests; D014325:Tromethamine / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000494:pharmacology* / Q000627:therapeutic use; D014552:Urinary Tract Infections / Q000188:drug therapy* / Q000453:epidemiology* / Q000209:etiology / Q000382:microbiology
D000890:Anti-Infective Agents; D014325:Tromethamine; D005578:Fosfomycin